Zoono Group Ltd (ASX: ZNO) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Zoono Group Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $14.96 million
P/E Ratio 28.90
Dividend Yield 0.00%
Shares Outstanding 280.27 million
Earnings per share -0.029
Dividend per share 0.03
Year To Date Return 141.46%
Earnings Yield 3.46%
Franking -
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Zoono Group Ltd (ASX: ZNO)
    Latest News

    a woman
    Share Market News

    This ASX biotech share just posted 144% half year revenue growth

    Shares in ASX biotech provider Zoono Group Ltd (ASX: ZNO) could move in early trade today after the group posted…

    Read more »

    a woman
    Share Market News

    Why the Zoono share price rocketed another 25% today

    The Zoono Group Ltd (ASX: ZNO) share price rocketed today after the company announced the appointment of an exclusive distributor…

    Read more »

    a woman
    Share Market News

    Why this small cap biotech has rocketed 2,511% in the last 5 months

    The Zoono Group Ltd (ASX: ZNO) share price has rocketed 22% higher so far today, taking 5-month returns to a…

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    04 Sep 2020 $0.0300 0.00% Final 21 Sep 2020

    ZNO ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Zoono Group Ltd

    Zoono Group Ltd is engaged in the research, development, and sale of a range of antimicrobial products in multiple countries. The company develops products suited for skin care, surface sanitizers, aerosol-based sprays, as well as acne products and mould remediation treatments. Geographically, it derives a majority of revenue from Australasia, Asia, United States, India, and also has a presence in United Kingdom and Europe.

    ZNO Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    17 Apr 2024 $0.07 $-0.01 -12.35% 63,329 $0.08 $0.08 $0.06
    15 Apr 2024 $0.08 $0.00 0.00% 34,149 $0.08 $0.08 $0.08
    11 Apr 2024 $0.08 $0.00 0.00% 28,682 $0.08 $0.08 $0.08
    10 Apr 2024 $0.08 $-0.02 -20.00% 67,139 $0.10 $0.10 $0.08
    09 Apr 2024 $0.10 $0.03 41.86% 117,690 $0.09 $0.10 $0.09
    08 Apr 2024 $0.07 $0.00 0.00% 65,384 $0.08 $0.08 $0.07
    05 Apr 2024 $0.08 $0.00 0.00% 200,857 $0.07 $0.08 $0.07
    04 Apr 2024 $0.07 $0.00 0.00% 51,909 $0.08 $0.08 $0.07
    03 Apr 2024 $0.07 $0.01 16.00% 381,027 $0.06 $0.07 $0.06
    02 Apr 2024 $0.06 $-0.03 -32.79% 931,120 $0.09 $0.09 $0.06
    28 Mar 2024 $0.09 $0.00 0.00% 434,799 $0.10 $0.10 $0.09
    27 Mar 2024 $0.10 $0.01 11.41% 435,975 $0.10 $0.10 $0.09
    26 Mar 2024 $0.09 $0.00 0.00% 1,145,493 $0.08 $0.10 $0.08
    25 Mar 2024 $0.08 $0.00 0.00% 897,271 $0.09 $0.10 $0.08
    22 Mar 2024 $0.09 $0.03 49.19% 1,267,957 $0.07 $0.09 $0.07
    21 Mar 2024 $0.06 $0.00 0.00% 304,535 $0.06 $0.06 $0.06
    20 Mar 2024 $0.06 $0.00 0.00% 314,519 $0.05 $0.06 $0.05
    19 Mar 2024 $0.05 $0.01 25.22% 1,519,138 $0.04 $0.06 $0.04

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    02 Jun 2023 Donald Clarke Issued 22,500 $1,035
    Rights issue.
    02 Jun 2023 Donald Clarke Issued 67,500 $3,375
    Rights issue.
    02 Jun 2023 Paul Hyslop Issued 4,963,168 $228,305
    Rights issue.
    02 Jun 2023 Elissa Hansen Issued 69,000 $3,450
    Rights issue.
    02 Jun 2023 Elissa Hansen Issued 23,000 $1,058
    Rights issue.
    02 Jun 2023 Paul Hyslop Issued 14,889,500 $744,475
    Rights issue.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr Donald Ian Clarke Non-Executive Director Apr 2017
    Mr Clarke was a Partner of Minter Ellison's Melbourne Corporate Group, from 1988- 2015. He currently acts as a consultant to them. Don has advised corporate clients on broad corporation law issues focused on equity capital markets, private equity, mergers and acquisitions and corporate restructures. He can draw on his first-hand experience as a corporate lawyer and a director, of Directors duties and responsibilities and best practice corporate governance, when advising on the legal and practical issues faced at head office and board level. He is Chairman of the Risk Committee.
    Ms Elissa Hansen Company SecretaryNon Executive Director Aug 2015
    Ms Hansen has over 20 years of experience advising boards and management on corporate governance, compliance, investor relations and other corporate related issues. She brings governance advice, ensuring compliance with the Listing Rules, Corporations Act, and other relevant legislation. She is member of the Risk Committee.
    Mr Paul Hyslop Managing Director Apr 2017
    Mr Hyslop founded the Company to address the need for a highly effective, alternative method of combating bacteria and microbes and quickly realized the business opportunity surrounding this technology. Prior to establishing Zoono, Paul was involved in several entrepreneurial ventures ranging from the establishment of a private car sales business in Auckland in 1990, to real estate development and business brokerage. He also set up a franchise business in the USA 2002-2005. Paul's experience in business development dates to the 1970s, when he started a personal-care services business after high school, grew it into eight locations and later sold it to his employees. He has also been a commercial flying instructor and Airline pilot, having flown commuter planes for Eagle Air, owned by Air New Zealand.
    Mr Barry Woolcott Global General ManagerChief Executive Officer Mar 2022
    -
    Paul Ravlich Chief Financial Officer
    -
    Lew Mackinnon Chief Operations Officer
    -
    Barry Woolcott Global General ManagerChief Executive Officer
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    Paul Russell Hyslop and Margaret Jane Morgan and Npt Meg Trustee Limited <Meg A/C> 74,447,500 39.20%
    Citicorp Nominees Pty Limited 11,247,662 5.92%
    Ubs Nominees Pty Ltd 9,289,905 4.89%
    MERRILL LYNCH (AUSTRALIA) NOMINEES PTY LIMITED 6,322,229 3.33%
    Brispot Nominees Pty Ltd <House Head Nominee A/C> 4,251,197 2.24%
    Buttonwood Nominees Pty Ltd 3,260,660 1.72%
    Mr Eelco Wiersma 2,873,420 1.51%
    Warbont Nominees Pty Ltd <Unpaid Entrepot A/C> 2,265,134 1.19%
    National Nominees Limited 2,062,125 1.09%
    Neweconomy Com Au Nominees Pty Limited <900 Account> 2,021,479 1.06%
    Lewis Andrew Craig Mackinnon 1,700,464 0.90%
    Hsbc Custody Nominees (Australia) Limited A/C 2 1,398,912 0.74%
    Woolcott Investments Limited <The Woolcott Investment A/C> 1,257,861 0.66%
    Hsbc Custody Nominees (Australia) Limited 938,422 0.49%
    Futin Pty Ltd 881,901 0.46%
    Bissapp Software Pty Ltd <Super Fund Account> 868,200 0.45%
    Merrill Lynch (Australia) Nominees Pty Limited <Equity Finance A/C> 757,588 0.40%
    Bnp Paribas Noms Pty Ltd <Drp> 752,702 0.40%
    Bissapp Software Pty Ltd <Bisapp Software Sf A/C> 630,860 0.33%
    Mr David Maher and Mrs Claudia Maher <D & C Maher S/F A/C> 627,605 0.33%

    Profile

    since

    Note